Wolfgang Pohl

3.8k total citations
85 papers, 1.2k citations indexed

About

Wolfgang Pohl is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology and Allergy. According to data from OpenAlex, Wolfgang Pohl has authored 85 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Pulmonary and Respiratory Medicine, 35 papers in Physiology and 13 papers in Immunology and Allergy. Recurrent topics in Wolfgang Pohl's work include Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Wolfgang Pohl is often cited by papers focused on Asthma and respiratory diseases (30 papers), Respiratory and Cough-Related Research (15 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (13 papers). Wolfgang Pohl collaborates with scholars based in Austria, Germany and United States. Wolfgang Pohl's co-authors include Alfred Kobsa, Jürgen Koenemann, Katharina Marth, Andreas Renner, Marco Idzko, Marina B. Klein, Gabriele Sachs, H Klech, Siegfried Gauggel and Felix Wantke and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Surgery and European Respiratory Journal.

In The Last Decade

Wolfgang Pohl

78 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Pohl Austria 18 402 349 206 170 114 85 1.2k
Stephen Kay United Kingdom 15 263 0.7× 329 0.9× 25 0.1× 156 0.9× 105 0.9× 45 971
Andy Liu United States 21 275 0.7× 511 1.5× 72 0.3× 97 0.6× 96 0.8× 110 1.7k
E. Haddi France 10 70 0.2× 266 0.8× 181 0.9× 338 2.0× 337 3.0× 12 884
Sungjin Park South Korea 18 117 0.3× 382 1.1× 81 0.4× 100 0.6× 7 0.1× 56 1.3k
Trafford Crump Canada 17 171 0.4× 36 0.1× 135 0.7× 126 0.7× 24 0.2× 100 1.3k
Saleh Alharbi Saudi Arabia 11 79 0.2× 60 0.2× 99 0.5× 84 0.5× 13 0.1× 38 812
Michael Bonert Canada 16 264 0.7× 77 0.2× 71 0.3× 45 0.3× 11 0.1× 43 793
Hyun Jin Choi South Korea 22 116 0.3× 97 0.3× 26 0.1× 38 0.2× 15 0.1× 62 1.1k
Marcus A. Badgeley United States 16 197 0.5× 56 0.2× 27 0.1× 613 3.6× 12 0.1× 21 2.0k
Ian Chen United States 16 873 2.2× 69 0.2× 22 0.1× 27 0.2× 23 0.2× 33 2.5k

Countries citing papers authored by Wolfgang Pohl

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Pohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Pohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Pohl more than expected).

Fields of papers citing papers by Wolfgang Pohl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Pohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Pohl. The network helps show where Wolfgang Pohl may publish in the future.

Co-authorship network of co-authors of Wolfgang Pohl

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Pohl. A scholar is included among the top collaborators of Wolfgang Pohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Pohl. Wolfgang Pohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wouters, Emiel F.�M., Robab Breyer‐Kohansal, Roland Buhl, et al.. (2023). Asthma Prevalence and Phenotyping in the General Population: The LEAD (Lung, hEart, sociAl, boDy) Study. Journal of Asthma and Allergy. Volume 16. 367–382. 17 indexed citations
2.
Hartl, Sylvia, Otto C. Burghuber, Emiel F.�M. Wouters, et al.. (2022). Aero-Allergen Sensitization in the General Population: Longitudinal Analyses of the LEAD (Lung Heart Social Body) Study. SHILAP Revista de lepidopterología. 12 indexed citations
4.
Brändle, Michael, Martin Brutsche, Emanuel Burri, et al.. (2022). Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial. Trials. 23(1). 790–790. 1 indexed citations
5.
Marth, Katharina, Andreas Renner, & Wolfgang Pohl. (2021). TRICOP – A Real-world effectiveness study with a single-inhaler extrafine triple therapy over 52 weeks in Austrian patients with COPD. Respiratory Medicine. 182. 106398–106398. 14 indexed citations
6.
Weissenbruch, Ranny van, Ludger Klimek, Gabriella Gálffy, et al.. (2020). <p>MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis</p>. Journal of Asthma and Allergy. Volume 13. 633–645. 4 indexed citations
7.
Price, David, Ludger Klimek, Gabriella Gálffy, et al.. (2020). Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma. Clinical and Molecular Allergy. 18(1). 15–15. 10 indexed citations
8.
Klimek, Ludger, David Price, Gabriella Gálffy, et al.. (2020). Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study. International Archives of Allergy and Immunology. 181(10). 754–764. 2 indexed citations
9.
Renner, Andreas, Julia Romanova, Boris Ferko, et al.. (2019). Safety, pharmacokinetics and pharmacodynamics of a novel anti-asthmatic drug, XC8, in healthy probands. Pulmonary Pharmacology & Therapeutics. 59. 101852–101852. 3 indexed citations
10.
Pohl, Wolfgang. (2011). Informatik: Kein Interesse?. 15–19.
11.
Pohl, Wolfgang, et al.. (2009). Informatik-Biber: Informatik-Einstieg und mehr.. 38–49.
12.
Klein, Marina B., Siegfried Gauggel, Gabriele Sachs, & Wolfgang Pohl. (2009). Impact of chronic obstructive pulmonary disease (COPD) on attention functions. Respiratory Medicine. 104(1). 52–60. 46 indexed citations
13.
Pohl, Wolfgang, et al.. (2007). Computer science contests in Germany. 3 indexed citations
14.
Pohl, Wolfgang. (2005). Informatik-Wettbewerbe in Deutschland - Eine Übersicht.. 25. 10–23.
15.
Pohl, Wolfgang, et al.. (2005). Adjustable maintenance dosing with budesonide/formoterol or budesonide: Double-blind study. Respiratory Medicine. 100(3). 551–560. 17 indexed citations
17.
Pohl, Wolfgang. (1997). LaboUr - Machine Learning for User Modeling.. International Conference on Human-Computer Interaction. 27–30. 8 indexed citations
18.
Pohl, Wolfgang. (1996). Learning About the User - User Modeling and Machine Learning. Publikationsdatenbank der Fraunhofer-Gesellschaft (Fraunhofer-Gesellschaft). 2 indexed citations
19.
Kindås-Mügge, Ingela, Wolfgang Pohl, Eva Závadová, et al.. (1996). ALVEOLAR MACROPHAGES OF PATIENTS WITH ADULT RESPIRATORY DISTRESS SYNDROME EXPRESS HIGH LEVELS OF HEAT SHOCK PROTEIN 72 mRNA. Shock. 5(3). 184–189. 20 indexed citations
20.
Pohl, Wolfgang, Austin B. Thompson, H Köhn, et al.. (1992). Serum Procollagen III Peptide Levels in Subjects with Sarcoidosis: A 5-Year Follow-up Study. American Review of Respiratory Disease. 145(2_pt_1). 412–417. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026